- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Healthcare stocks languish in 1996
U.S. healthcare stocks generally turned in a lackluster performancein 1996, according to the results of Annual Healthcare IndustryReport, a year-end survey issued this week by WDI Capital Marketsof Hilton Head, SC. Overall, healthcare stocks were up a
U.S. healthcare stocks generally turned in a lackluster performancein 1996, according to the results of Annual Healthcare IndustryReport, a year-end survey issued this week by WDI Capital Marketsof Hilton Head, SC. Overall, healthcare stocks were up a meager2.7% in 1996, compared with growth of 40% in 1995. The industrywas down 4.7% in 1994 and 9.4% in 1993.
Within medical imaging, the imaging services segment saw its sharesgrow 43.5% for the year, a performance that led all healthcaresegments but was still down several points from 1995's hefty growthof 52%. The segment was driven by growth in shares of Health Images,which gained 129%; Alliance Imaging, which grew 105%; MedicalResources, up 103%; and SMT Health Services, up 95%.
The imaging devices segment ticked up a mere 4.3%, compared withgrowth of 75.9% in 1995, according to the WDI survey. Gains of97% by both Acuson and ADAC Laboratories were offset by a 47%decline at Elscint (including a 5-for-1 reverse stock split),a 41% drop in Fischer Imaging shares, and a 43% decline in Norland'sstock. Other firms whose shares posted gains in 1996 include OECMedical, up 54%; Lunar, up 27%; and Hologic, up 21%.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
